Download Infographic Overview The concept of mRNA as a vaccine platform has evolved over several decades, using host cells to produce antigens. mRNA vaccines can induce both B cell and T cell immune responses and avoid...
In 2021, surveillance systems in multiple countries detected a safety signal for myocarditis and pericarditis after mRNA COVID‑19 vaccination, particularly in adolescent and young adult males. Three years later, the...
Broad Immunity from Naturally Occurring Influenza Antibodies The findings indicate that broadly neutralizing human antibodies can target conserved epitopes in the HA head, not just the stem, broadening the conceptual...
Vaccination in pregnancy has quietly become one of the most powerful tools we have to protect both mothers and their infants in the first months of life. During this period, infants are highly vulnerable to severe...
This narrative review by Gromer et al. provides a comprehensive synthesis of the long-observed but poorly characterized relationship between vaccine reactogenicity—short-term, inflammatory adverse events—and...
In Asia, major producers are scaling up both legacy and next-generation vaccine capacity. India’s Serum Institute, the world’s largest vaccine manufacturer, recently announced expanded partnerships with African...
Western vaccine manufacturers Pfizer-BioNTech: Expanded RSV vaccine recommendations for older adults The Centers for Disease Control and Prevention (CDC) updated its guidance to recommend the Pfizer-BioNTech RSV vaccine...
Penn researchers unveil groundbreaking mRNA avian flu vaccine In a significant stride toward pandemic preparedness, researchers at the Perelman School of Medicine at the University of Pennsylvania have developed an...
The development of mRNA technology marks one of the most groundbreaking moments in modern medicine. Once relegated to experimental laboratories, it emerged as a beacon of hope during the COVID-19 pandemic, enabling the...
Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination enhances immune responses and...